Advertisement

Russian Journal of General Chemistry

, Volume 88, Issue 4, pp 839–842 | Cite as

Synthesis of New 1,4-Benzodioxanуl-1,2,4-triazole Derivatives

  • A. B. Sargsyan
  • A. S. Avakyan
  • S. O. Vartanyan
  • G. M. Stepanyan
  • R. V. Paronikyan
Letters to the Editor
  • 14 Downloads

Abstract

The reaction of 5-(1,4-benzodioxan-2-yl)-4H-1,2,4-triazole-3-thiol with N-substituted chloroacetic acid amides obtained by condensation of chloroacetyl chloride with various primary amines furnished a series of S-amidomethyl derivatives. The corresponding thiazolotriazolone prepared from 2-[5-(1,4-benzodioxan-2-yl)-4H-1,2,4-triazol-3-ylthio]acetic acid reacted with aromatic aldehydes to form arylidene derivatives.

Keywords

1,4-benzodioxane triazole chloroamides thiazolotriazolone chloroacetic acid 

References

  1. 1.
    Avakyan, A.S., Vartanyan, S.O., Sarkisyan, A.B., and Markaryan, E.A., Khim. Zh. Armenii, 2006, vol. 59, no. 4, p. 130.Google Scholar
  2. 2.
    Vartanyan, S.O., Margaryan, E.A., Arutyunyan, S.A., Martirosyan, O.M., and Shirinyan, E.A., Vestn. MANEB, 2003, vol. 8, no. 4, p. 135.Google Scholar
  3. 3.
    Vartanyan, S.O., Avakyan, A.S., Sargsyan, A.B., Arutyunyan, S.A., Noravyan, O.S., and Tsatinyan, A.S., Russ. J. Org. Chem., 2016, vol. 52, no. 2, p. 244. doi 10.1134/S107042801602CrossRefGoogle Scholar
  4. 4.
    Avakyan, A.S., Vartanyan, S.O., Sargsyan, A.B., and Margaryan, E.A., Russ. J. Org. Chem., 2014, vol. 50, no. 3, p. 434. doi 10.1134/S1070428014030233CrossRefGoogle Scholar
  5. 5.
    Al-Omair, M.A., Sayed, A.R., and Youssef, M.M., Molecules, 2015, vol. 20, no. 2, p. 2591. doi 10.3390/molecules20022591CrossRefGoogle Scholar
  6. 6.
    Maddila, S., Pagadala, R., and Jonnalagadda, S.B., Lett. Org. Chem., 2013, vol. 10, no. 10, p. 693. doi 10.2174/157017861010131126115448CrossRefGoogle Scholar
  7. 7.
    Sharma, J., Ahmad, S., and Shamsher, A.M., J. Chem. Pharm. Res., 2012, vol. 4, no. 12, p. 5157.Google Scholar
  8. 8.
    Kaur, R., Dwivedi, A.R., Kumar, B., and Kumar, V., Anticancer Agents Med. Chem., 2016, vol. 16, no. 4, p. 465. doi 10. 2174/1871520615666150819121106CrossRefGoogle Scholar
  9. 9.
    Mallesha, L. and Mohana, K.N., Eur. J. Chem., 2011, vol. 2, no. 2, p. 193. doi 10.5155/eurjchem.2.2.193-199.282CrossRefGoogle Scholar
  10. 10.
    Zhou, C.H. and Wang, Y., Curr. Med. Chem., 2012, vol. 19, no. 2, p. 239. doi 10.2174/092986712803414213CrossRefGoogle Scholar
  11. 11.
    Keri, R.S., Patil, S.A., Budagumpi, S., and Nagaraja, B.M., Chem. Biol. Drug Des., 2015, vol. 86, no. 4, p. 410. doi 10.1111/cbdd.12527CrossRefGoogle Scholar
  12. 12.
    Barbuceanu, S.-F., Saramet, I., Almajan, G.L., Draghici, C., Tarcomnicu, I., and Bancescu, G., Rev. Chim., 2008, vol. 59, no. 9, p. 963.Google Scholar
  13. 13.
    Rukovodstvo po provedeniyu doklinicheskikh issledovanii lekarstvennykh sredstv (A Guide to Preclinical Drug Research), Mironov, A.N., Ed., Moscow: Meditsina, 2012.Google Scholar
  14. 14.
    Mashkovskii, M.D., Lekarstvennye sredstva (Drugs), Moscow: Novaya Volna, 2010.Google Scholar

Copyright information

© Pleiades Publishing, Ltd. 2018

Authors and Affiliations

  • A. B. Sargsyan
    • 1
  • A. S. Avakyan
    • 1
  • S. O. Vartanyan
    • 1
  • G. M. Stepanyan
    • 1
  • R. V. Paronikyan
    • 1
  1. 1.Mndzoyan Institute of Fine Organic Chemistry, Scientific Technological Center of Organic and Pharmaceutical ChemistryNational Academy of Sciences of the Republic of ArmeniaYerevanArmenia

Personalised recommendations